By: Jared Kaltwasser
A new meta-analysis of chimeric antigen receptor (CAR) T-cell therapy in patients with multiple myeloma (MM) suggests the treatment has a strong
Jared Kaltwasser is a healthcare and business writer whose work has appeared in various publications, including AJMC - The American Journal of Managed Care, Contagion_Live, and Managed Healthcare Executive. With a focus on healthcare topics, Jared covers a wide range of subjects, from disease and treatment advancements to healthcare management and cost-effectiveness.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
This information evolves through artificial intelligence and human feedback. Improve this profile .